ArticleMedComm2023

Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti-programmed death 1/programmed death ligand 1.

Yuancai Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.